198 related articles for article (PubMed ID: 32373223)
1. Molecular characteristics of synchronous multiple gastric cancer.
Wang A; Li Z; Wang M; Jia S; Chen J; Ji K; Ji X; Zong X; Wu X; Zhang J; Li Z; Zhang L; Hu Y; Bu Z; Zheng Q; Ji J
Theranostics; 2020; 10(12):5489-5500. PubMed ID: 32373223
[No Abstract] [Full Text] [Related]
2. Comprehensive mutation profiling of mucinous gastric carcinoma.
Rokutan H; Hosoda F; Hama N; Nakamura H; Totoki Y; Furukawa E; Arakawa E; Ohashi S; Urushidate T; Satoh H; Shimizu H; Igarashi K; Yachida S; Katai H; Taniguchi H; Fukayama M; Shibata T
J Pathol; 2016 Oct; 240(2):137-48. PubMed ID: 27313181
[TBL] [Abstract][Full Text] [Related]
3. Clonality analysis of synchronous gastro-oesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing.
Xing X; Jia S; Wu J; Feng Q; Dong B; Li B; Jia Y; Shan F; Li Y; Zhang Y; Hu Y; Wang X; Liu X; Yu W; Zhang L; Bu Z; Wu A; Li Z; Ji J
J Pathol; 2017 Oct; 243(2):165-175. PubMed ID: 28671728
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
[TBL] [Abstract][Full Text] [Related]
5. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
[TBL] [Abstract][Full Text] [Related]
6. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
[TBL] [Abstract][Full Text] [Related]
7. Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China.
Zhang Y; Liu X; Fan Y; Ding J; Xu A; Zhou X; Hu X; Zhu M; Zhang X; Li S; Wu J; Cao H; Li J; Wang Y
Int J Cancer; 2006 Dec; 119(11):2592-6. PubMed ID: 16929514
[TBL] [Abstract][Full Text] [Related]
8. Association of a novel point mutation in MSH2 gene with familial multiple primary cancers.
Hu H; Li H; Jiao F; Han T; Zhuo M; Cui J; Li Y; Wang L
J Hematol Oncol; 2017 Oct; 10(1):158. PubMed ID: 28974240
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic evaluation of DNA mismatch repair markers in 2 cases of synchronous histomorphologically distinct gastric adenocarcinomas with gastrointestinal stromal tumors of the proximal small bowel.
Athanassiou E; Vamvakopoulou DN; Zacharoulis D; Paroutoglou G; Sioutopoulou D; Tepetes K; Nomikos I; Vamvakopoulos NC
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):288-90. PubMed ID: 20090515
[TBL] [Abstract][Full Text] [Related]
10. Identification of New Genes Involved in Germline Predisposition to Early-Onset Gastric Cancer.
Herrera-Pariente C; Capó-García R; Díaz-Gay M; Carballal S; Muñoz J; Llach J; Sánchez A; Bonjoch L; Arnau-Collell C; Soares de Lima Y; Golubicki M; Jung G; Lozano JJ; Castells A; Balaguer F; Bujanda L; Castellví-Bel S; Moreira L
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525650
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study.
Liu H; Li F; Zhu Y; Li T; Huang H; Lin T; Hu Y; Qi X; Yu J; Li G
Oncotarget; 2016 Jul; 7(28):43894-43906. PubMed ID: 27270314
[TBL] [Abstract][Full Text] [Related]
12. Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.
Röcken C; Amallraja A; Halske C; Opasic L; Traulsen A; Behrens HM; Krüger S; Liu A; Haag J; Egberts JH; Rosenstiel P; Meißner T
Genome Med; 2021 Nov; 13(1):177. PubMed ID: 34749812
[TBL] [Abstract][Full Text] [Related]
13. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
[TBL] [Abstract][Full Text] [Related]
14. Clonal Structures of Regionally Synchronous Gastric Adenomas and Carcinomas.
Jung SH; Kim SY; An CH; Lee SH; Jung ES; Park HC; Kim MS; Chung YJ; Lee SH
Clin Cancer Res; 2018 Oct; 24(19):4715-4725. PubMed ID: 29945994
[No Abstract] [Full Text] [Related]
15. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
[TBL] [Abstract][Full Text] [Related]
16. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
17. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Zang YS; Dai C; Xu X; Cai X; Wang G; Wei J; Wu A; Sun W; Jiao S; Xu Q
Cancer Med; 2019 Aug; 8(10):4699-4708. PubMed ID: 31270941
[TBL] [Abstract][Full Text] [Related]
19. The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.
Laitman Y; Herskovitz L; Golan T; Kaufman B; Paluch SS; Friedman E
Fam Cancer; 2012 Jun; 11(2):243-7. PubMed ID: 22219001
[TBL] [Abstract][Full Text] [Related]
20. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
